🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This morning Jamie Wood kicked off the presidential session with is powerful poems on Leukaemia #BSH2024. It was funny and emotional to listen such precious words BSH - Haematology eClinicalMedicine – The Lancet Discovery Science

I am attending the 5th SIOPE 🎗️ Annual Meeting on 12-17 May 2024, in Milan #SIOPEurope2024. Please feel free to contact me to discuss potential submissions or collaborations with eClinicalMedicine – The Lancet Discovery Science

Important session at the #SIOPEurope2024 on the use of AI in childhood cancer. Dr Pamela Kearns highlighted how AI is advancing in oncology but is still little used in paediatric oncology eClinicalMedicine – The Lancet Discovery Science SIOPE 🎗️

Join Vincenzo Giacco, PhD, Senior Editor at eClinicalMedicine – The Lancet Discovery Science, as he co-chairs our upcoming Lancet Webinar exploring the trends and challenges of lung cancer in Asia. Register now: hubs.li/Q02CfM950 🗓️ Jul 9, 09:30 BST/16:30 CST

Congratulations to our authors and peer reviewers, whose expertise and hard work enable us to continue publishing some of the best science for better lives. This is as much your achievement!

Hear from our Series authors during our upcoming webinar on the trends and challenges of #LungCancer in Asia as part of our cross-journal Review Series from eClinicalMedicine – The Lancet Discovery Science, The Lancet Reg Health-Southeast Asia, and The Lancet Reg Health-West Pacific. Register now: hubs.li/Q02CtvlW0 🗓️ Jul 9, 09:30 BST/16:30 CST

Check out our last editorial on AI in childhood cancer highlighting potential and gaps in this field SIOPE 🎗️ The potential role of Artificial Intelligence in transforming childhood cancer care - eClinicalMedicine – The Lancet Discovery Science thelancet.com/journals/eclin…

Lung cancer is a significant public health issue in Asia, representing one of the leading causes of cancer-related mortality. A new Series from eClinicalMedicine – The Lancet Discovery Science, The Lancet Reg Health-West Pacific, and The Lancet Reg Health-Southeast Asia explores the trends and challenges of lung cancer in Asia: hubs.li/Q02FM_DQ0

Join Nature Cancer and Nature Communications for an exclusive Webinar on "Microbiome in cancer immunotherapy" on Wednesday 18th Sept 2024. Don’t miss the chance to learn from our speakers and engage with cancer community. cassyni.com/events/FfJmtNo… – secure your spot today!👇

📢Inside September Issue: have a look at📰Nature Cancer issue featuring #CART cell therapy, #ProstateCancer, SOS1 and KRAS-G12C inhibitor, mammary #carcinoma models, #melanoma immunotherapy-associated toxicity, and much more

Wonderful first day #ENAsymp24 and exciting session on KRAS targeting with Channing Der, Norbert Kraut, and Jayesh Desai. This is really the best time for KRAS research, I'm proud to give our contribution too! KRASKickers Johns Hopkins Kimmel Cancer Center Johns Hopkins Medicine

🚨Fantastic morning session at #ENASymp24 with four great talks by G Curigliano MD PhD Paolo Tarantino Barbara Pistilli Raffaele Colombo on antibody-drug conjugates to treat cancer ⭐️Very glad to see different perspectives and relevant results on ADCs Nature Cancer

Phase 1 data on the HIF-2a inhibitor casdatifan presented by Toni Choueiri, MD at #ENASymp24. Among 86 pts with advanced solid tumors, the toxicity profile appeared favorable (mostly low grade anemia, fatigue, hypoxia), with an encouraging preliminary activity (ORR 25-34%). Dana-Farber

Thrilled to represent Nature Cancer at #ESMOTAT2025 in Paris with fantastic sessions on targeted therapies and early-phase clinical trial studies. ESMO - Eur. Oncology

Have a look at our last Meeting Reports from the last ESMO Targeted Anticancer Therapies Congress in Paris Nature Cancer ESMO - Eur. Oncology 👉nature.com/articles/s4301…

Inside April Issue: have a look at Nature Cancer issue featuring GEP-NETs, CART, prostate cancer, renal cell carcinoma, bacteria in cancer therapy, gallbladder lesions, lung cancer, ESMO TAT reports, and much more 👉nature.com/natcancer/

Excited to be attending SIOP Europe Annual Meeting in Budapest representing Nature Cancer. Looking forward to connecting—feel free to say hi or reach out if you'd like to chat about publishing, research, collaborations SIOPE 🎗️ SIOP International

Join us for discussions and panels on the latest research advancing our understanding of the tumor ecosystem and its influence over cancer development and treatment Nature Conferences Nature Portfolio 👉natureconferences.streamgo.live/tumor-ecosyste…

Excited to be attending #ASCO25! If you're curious about Nature Cancer or want to explore publishing opportunities, come say hello. I'm always happy to connect and chat about research—looking forward to insightful conversations with the oncology community! Nature Cancer ASCO

Task force of oncology editors reunited to support the cancer community at #ASCO25! Even if the work makes us compatitors at times, we're all friends in the fight. 💪❤️ Vania Wisdom Nature Cancer Nature Medicine The Lancet The Lancet Oncology